[S3 guideline by the German Society of Digestive and Metabolic Diseases and the Competence Network of Chronic Inflammatory Bowel diseases on diagnosis and therapy of ulcerative colitis. An update].
Hoffmann
Jörg C
JC
Medizinische Klinik I mit Schwerpunkt Gastroenterologie/Infektiologie/Rheumatologie Charité, Universitätsmedizin Berlin Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin. joerg.hoffmann@charite.de
Zeitz
Martin
M
D000284:Administration, Oral; D000285:Administration, Rectal; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000191:economics; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D004305:Dose-Response Relationship, Drug; D016099:Endoscopy, Gastrointestinal; D019317:Evidence-Based Medicine / Q000191:economics; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use; D019804:Mesalamine / Q000008:administration & dosage; D009313:National Health Programs / Q000191:economics; D010289:Parenteral Nutrition, Total
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D019804:Mesalamine